Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Affiliations

Children's National Medical Center - Chairman of the NF Consortium

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

AeRang Kim, MD, PhD

Children's National Research Institute

Moderately Similar
7 trials

Shared therapeutic areas:

Neurofibromatosis 1

Worked with same sponsors:

Children's National Research Institute
Similarity Score30%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Moderately Similar
19 trials

Shared therapeutic areas:

Neurofibromatosis 1

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Roger J. Packer, MD

Children's National Research Institute

Moderately Similar
5 trials

Shared therapeutic areas:

Neurofibromatosis 1

Worked with same sponsors:

Children's National Research InstituteNational Cancer Institute (NCI)
Similarity Score30%

Jason R Fangusaro

Pediatric Brain Tumor Consortium

Moderately Similar
2 trials

Shared therapeutic areas:

Neurofibromatosis 1

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Vanessa Merker, PhD

Massachusetts General Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Neurofibromatosis 1
Similarity Score30%

Brigitte C. Widemann, MD

National Cancer Institute (NCI)

Moderately Similar
6 trials

Shared therapeutic areas:

Neurofibromatosis 1

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Richard R. Anderson, MD

Massachusetts General Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Neurofibromatosis 1
Similarity Score30%

Steven Pans, MD

Universitaire Ziekenhuizen KU Leuven

Moderately Similar
2 trials

Shared therapeutic areas:

Neurofibromatosis 1
Similarity Score30%

Mary Kay Koenig, MD

The University of Texas Health Science Center, Houston

Moderately Similar
3 trials

Shared therapeutic areas:

Neurofibromatosis 1
Similarity Score30%

Priya Kumthekar, MD

Northwestern University

Moderately Similar
3 trials

Shared therapeutic areas:

Neurofibromatosis 1

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00634270Phase 2StudyDirector

A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas

Neurofibromatosis Type 1
Completed

All 1 trials loaded